Highlights Eaton Vance Ohio Municipal Income Trust

Equities

EVO

US27826G1094

Delayed Nyse Other stock markets 03:48:08 2019-01-18 pm EST			5-day change	1st Jan Change
12.62 ^USD	+0.08%		-0.24%	+3.95%

Apr. 25	H.C. Wainwright Adjusts Price Target on Evotec to $11 From $14, Keeps Buy Rating	MT
Apr. 24	Top Midday Decliners	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Top Midday Decliners	Apr. 24	MT
Sector Update: Health Care Stocks Rise Pre-Bell Wednesday	Apr. 24	MT
Evotec, Variant Bio Launch Partnership to Develop Treatments for Fibrosis	Apr. 18	MT
Evotec Grants Claris Ventures Portfolio Biotech Firms Access to Testing Platform	Mar. 06	MT
Evotec Unit, Advanced BioScience Expand Agreement to Develop Antibodies Against HIV	Feb. 07	MT
Evotec Says Former CEO Failed to Disclose Stock Trades Over 3 Years	Jan. 22	MT
Evotec Collaborates With Crohn's & Colitis Foundation on Inflammatory Bowel Disease Therapies	Jan. 10	MT
Evotec Partners With Owkin to Accelerate Therapeutics Pipeline Using Artificial Intelligence	Jan. 04	MT
Federal Reserve Outlook Pushes Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday	Dec. 14	MT
Evotec Teams Up With Charite Universitatsmedizin Berlin to Generate Molecular Patient Database	Dec. 14	MT
Evotec Q3 Net Loss Narrows as Revenue Rises; Reaffirms 2023 Revenue Outlook	Nov. 08	MT
Novo Nordisk, Evotec Launch Drug Discovery Accelerator for Cardiometabolic Diseases, Blood and Endocrine Disorders	23-09-26	MT
Evotec Q2 Net Loss Narrows, Revenue Decreases	23-08-29	MT
Evotec, Bristol-Myers Squibb Enter Exclusive Global License Agreement on Selected Neuroscience Programs	23-07-11	MT
Evotec's Preliminary 2022 Operating Income Declines, Revenue Rises	23-03-28	MT
Evotec, Bristol-Myers Squibb Extend Partnership on Neurodegenerative Diseases for Eight Years	23-03-28	MT
Evotec Expands Drug Discovery Partnership With Related Sciences	23-02-09	MT
Evotec, Johnson & Johnson's Janssen Biotech Enter Cancer Drug Development Collaboration	23-01-26	MT
Evotec, Bristol-Myers Squibb Expand Neuroscience Collaboration	22-12-16	MT
Evotec's Q3 Swings to Loss While Revenue Rises; Company Reiterates Full-Year 2022 Revenue Guidance	22-11-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Eaton Vance Ohio Municipal Income Trust

Equities

EVO

US27826G1094

Highlights

Filters